CTR

LinkDaddy Announces CTR Manipulation Service for SEO & Improved Ranking

Retrieved on: 
Tuesday, March 12, 2024
Map, Marketing, Social media, Internet, CTR, Online shopping

LinkDaddy has announced a new update to its clickthrough rate manipulation service to help more businesses improve their visibility on Google Maps.

Key Points: 
  • With over 90% of global internet traffic originating from Google search, Maps, or Images, according to SparkToro, ranking highly in organic search results is critical.
  • Artificially increasing CTR works by manipulating the signals search engines use for ranking - such as factors like interactions, impressions, and bounce rate.
  • This service joins LinkDaddy's existing SEO and backlink offerings to provide an all-in-one visibility solution for businesses, and combining the CTR with other organic strategies maximizes the potential for high rankings and inbound traffic.
  • With the CTR manipulation service, you get a higher chance of boosting your SEO ranking for less time and money."

Clinical Trials Information System Webinar: Last Year of Transition, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 March 2024, 13:00 (CET) to 25 March 2024, 17:30 (CET)

Retrieved on: 
Sunday, March 10, 2024
EMA, Primary and secondary legislation, Location, Clinical trial, Vimeo, European Medicines Agency, SME, CTR

Since 31 January 2023, it is mandatory for sponsors to submit all initial clinical trial applications via CTIS.

Key Points: 
  • Since 31 January 2023, it is mandatory for sponsors to submit all initial clinical trial applications via CTIS.
  • In less than a year, from 31 January 2025 onwards sponsors will need to comply with their obligations under the CTR and its Delegated Acts.
  • This EMA-hosted webinar is open to all sponsor organisations, including pharmaceutical companies, contract research organisations, small and medium-sized enterprises (SMEs) and academic organisations.
  • Attendees are invited to fill out a short feedback survey via Slido that will be available after the event.

BENlabs Unveils the Most Advanced A/B Testing Features for Its TubeBuddy Browser Extension

Retrieved on: 
Thursday, March 7, 2024
AI, Engagement, CTR, Medical device

LOS ANGELES, March 7, 2024 /PRNewswire/ -- BENlabs, the leading entertainment AI company, today announced the most recent updates to its A/B Testing feature.

Key Points: 
  • LOS ANGELES, March 7, 2024 /PRNewswire/ -- BENlabs, the leading entertainment AI company, today announced the most recent updates to its A/B Testing feature.
  • This latest product release is part of TubeBuddy, the renowned browser extension designed to enrich the YouTube experience for Creators.
  • Exclusive enhancements to the A/B Testing features are available now for TubeBuddy Creators and are set to revolutionize the way creators optimize their content for better engagement and  higher reach.
  • Creators can access it by updating their TubeBuddy browser extension to the latest version.

Spectrum Science Acquires Continuum Clinical, Amplifying Patient Recruitment Capabilities

Retrieved on: 
Thursday, February 8, 2024
Acquisition, Science, Blue chip, Partnership, Culture, Growth, Health, SCOPE, Continuum, MERIS, Marketing, Clinical trial, Patient, CTR, Drug development, Advertising, Pharmaceutical industry

WASHINGTON and NORTHBROOK, Ill., Feb. 8, 2024 /PRNewswire/ -- Spectrum Science, an independent, integrated healthcare and scientific marketing, communications, media and strategic services firm focused on the pharmaceutical, biotech and broader life science industries, today announced the acquisition of Continuum Clinical, a global clinical trial recruitment and engagement solutions provider with a 30-year track record of success elevating interest, increasing access and enhancing experiences in clinical trials. Spectrum purchased Continuum from Blue Chip Worldwide, an independent, full-service, creative marketing agency growing brands through creative commerce. Details of the transaction were not disclosed.

Key Points: 
  • Spectrum purchased Continuum from Blue Chip Worldwide, an independent, full-service, creative marketing agency growing brands through creative commerce.
  • Continuum will merge with Spectrum's existing clinical trial recruitment (CTR) strategic pillar, bolstering the company's current offering in several critical ways, including adding overall depth and breadth of capabilities, as well as bringing a large and diverse client roster.
  • While many companies are vying to solve this industrywide challenge, the patient recruitment sector has remained highly fragmented and commoditized, with few full-service, strategic solution providers, leading to disjointed patient experiences and dissatisfied sponsors.
  • "We are thrilled to welcome the extraordinarily talented and established Continuum Clinical team to Spectrum and cannot wait to see what we're able to accomplish together as a unified and powerful force in the patient recruitment space," said Jonathan Wilson, CEO of Spectrum Science.

New Gmail and Yahoo authentication changes - GetResponse explores the real impact for businesses with new email deliverability research

Retrieved on: 
Thursday, February 1, 2024
Marketing, CTR, Gmail, Partnership, Yahoo!, Content, Research, ROI, Risk, Internet service provider

WILMINGTON, Del., Feb. 1, 2024 /PRNewswire/ -- Ahead of new Gmail and Yahoo email regulations this week, GetResponse, a leading global email marketing platform, has released new internal research on email deliverability to explore the potential impact for those who comply.

Key Points: 
  • WILMINGTON, Del., Feb. 1, 2024 /PRNewswire/ -- Ahead of new Gmail and Yahoo email regulations this week, GetResponse, a leading global email marketing platform, has released new internal research on email deliverability to explore the potential impact for those who comply.
  • The study also reveals a significant increase in click-through rates (CTR), from 2.83% for free domains to over 4% for custom domains.
  • Michael Leszczynski, Head of Content Marketing & Partnerships at GetResponse, comments: "These industry changes will impact everyone.
  • They can even get a free custom domain for a year if they sign up for a discounted annual plan".

Clinical trials' transition to new EU system - one year left

Retrieved on: 
Sunday, February 4, 2024
CTIS, CTR, CTD, NCA, European Medicines Agency, European Commission, Clinical trial

All ongoing clinical trials in the EU must be transitioned to the Clinical Trials Information System (CTIS) by 31 January 2025.

Key Points: 
  • All ongoing clinical trials in the EU must be transitioned to the Clinical Trials Information System (CTIS) by 31 January 2025.
  • This date marks the end of a three-year transition period that began when the Clinical Trials Regulation (CTR) became applicable in the EU.
  • Ongoing clinical trials do not need to be halted or ended during the transition from the previous legal regime, the Clinical Trials Directive (CTD), to the Clinical Trials Regulation.
  • To help sponsors make the transition, there is guidance available, a best practice guide for sponsors of multinational clinical trials, and additional support materials.

ACT EU Training for non-commercial sponsors: Transitioning trials to the CTR (CTIS) , Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 9 February 2024, 10:00 (CET) to 9 February 2024, 13:00 (CET)

Retrieved on: 
Sunday, February 4, 2024
Primary and secondary legislation, CTIS, Clinical trial, EMA, CTR, European Economic Area, Location, Vaccine

Moreover, the event will provide useful training in preparing new clinical trials following the Clinical Trial Regulation (CTR).

Key Points: 
  • Moreover, the event will provide useful training in preparing new clinical trials following the Clinical Trial Regulation (CTR).
  • Sponsors, therefore, need to transition any trials that will continue after 30 January 2025 from the Clinical Trials Directive to the legal framework of the CTR.
  • During the event, representatives from the Member States and EMA will provide guidance and resources to support non-commercial sponsors in transitioning their trials to the Clinical Trials Information System (CTIS).
  • Please subscribe to the clinical trials newsletter for updates on the availability of video recordings for EMA events related to clinical trials.

ClearBridge MLP Funds Announce Proposed Mergers and Updates for Tender Offers

Retrieved on: 
Friday, January 26, 2024
Banking, Professional Services, Finance, Proxy, ClearBridge Investments, Funding, Schedule, MRPS, Shareholder, Prospectus, CEM, Fund, Form, EMO, Letter, CTR, Security (finance)

Management and each Fund’s investment adviser do not anticipate any material portfolio turnover as a result of the proposed merger.

Key Points: 
  • Management and each Fund’s investment adviser do not anticipate any material portfolio turnover as a result of the proposed merger.
  • Each Fund’s tender offer period is expected to close on or about June 18, 2024.
  • The specific terms of each Fund’s tender offer will be described in a Schedule TO filed with the SEC on a later date.
  • The tender offers are not contingent upon the successful completion of the mergers.

The HOW Agency Wins Gold AVA Digital Award for Social Campaign, Digital Marketing

Retrieved on: 
Thursday, January 25, 2024
Gold, Digital marketing, Digital, 5WPR, HOW, CTR, Professional, Marketing, EVP, AMCP

NEW YORK, Jan. 25, 2024 /PRNewswire/ -- The HOW Agency, a full-service digital agency and subsidiary of 5WPR, is pleased to announce its work for client David's Vacation Club Rentals (DVCR) has been recognized as a Gold winner in the 2024 AVA Digital Awards in the Social Campaign, Digital Marketing category.

Key Points: 
  • NEW YORK, Jan. 25, 2024 /PRNewswire/ -- The HOW Agency , a full-service digital agency and subsidiary of 5WPR , is pleased to announce its work for client David's Vacation Club Rentals (DVCR) has been recognized as a Gold winner in the 2024 AVA Digital Awards in the Social Campaign, Digital Marketing category.
  • AVA Digital recognizes outstanding achievement by creative professionals involved in the concept, direction, design, and production of media that is part of the evolution of digital communications.
  • AVA Digital Awards is sponsored and judged by the Association of Marketing and Communication Professionals (AMCP).
  • A list of Platinum and Gold Winners can be found on the AVA Digital Awards website at www.avaawards.com .

Expanding horizons: Turismo Andalucía and Huawei join forces to attract Chinese travellers

Retrieved on: 
Thursday, January 18, 2024
Chinese New Year, Huawei Mobile Services, Culture, City, Ecosystem, Sport, Travel, CTV, CTR, Council, Turismo, Tourism

Havas Spain recently won the media promotion bid for Turismo Andalucía in Asia, with Petal Ads as the selected platform of choice to raise Andalusia's visibility among Chinese travellers and drive meaningful conversions.

Key Points: 
  • Havas Spain recently won the media promotion bid for Turismo Andalucía in Asia, with Petal Ads as the selected platform of choice to raise Andalusia's visibility among Chinese travellers and drive meaningful conversions.
  • Attracting Chinese tourists is crucial for Turismo Andalucía.
  • Petal Ads has been chosen as a key mobile advertising platform for Turismo Andalucía, representing a strategic choice to engage with Chinese users owing to its ability to target high-value Chinese audiences and massive reach.
  • Employing market intelligence is essential to attract these customers and boost Andalusia's worldwide prominence," said Lisardo Morán, General Manager at Turismo Andalucía.